LeMaitre Vascular (LMAT) Reports Q2 Loss of $0.06, Misses by a Penny
More News related to LMAT
- LeMaitre Vascular to Present at Canaccord Adams 3rd Annual Cardiovascular Conference
- Morning Movers 10/29: ROIAK, GIGA, HS, TBL, KDN, CATM Higher; TSPT, CPF, CYTK, KSP, FSLR, CLUB, PODD Lower
- After-Hours Movers 10/28: GIGA, EGHT, CATM, AKAM, LMAT, LNC Higher; FSLR, FLS, FALC, OI Lower
- LeMaitre Vascular (LMAT) Tops Q3 EPS by 7c
- LeMaitre Vascular Q3 2009 Record Sales $13.3mm (up 11%), Op. Profit $1.3mm
More News related to Earnings
- Piper Jaffray Initiates Coverage on Hain Celestial Group (HAIN) with a Neutral; Upside Potential is Limited
- Piper Jaffray Initiates Coverage on Green Mountain Coffee (GMCR) with an Overweight; Several Potential Catalysts
- Piper Jaffray Initiates Coverage on B&G Foods (BGS) with a Neutral; Stock Reflects Fair Valuation
- Piper Jaffray Initiates Coverage on Del Monte Foods (DLM) with a Neutral
- Longbow Starts KR, WFMI at Buy, SWY, SVU at Neutral
LeMaitre Vascular, Inc. (Nasdaq: LMAT) reports a Q2 loss of $0.06, 1 cent lower than the analyst estimate of ($0.05). Revenues for the quarter were $12.7 million, versus the consensus of $11.91 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
